The 13th Annual Meeting of the Asian Organization for Crohn’s and Colitis（AOCC2025）
Advanced Search

Session Details

Oral PresentationOral Presentaion

Oral Oresentation 1

Fri. Jul 11, 2025 9:00 AM - 10:15 AM JST
Fri. Jul 11, 2025 12:00 AM - 1:15 AM UTC
Room Ⅲ(Makuhari Messe Meeting Room 201)
Chair:Fumihito Hirai, Kei Moriya
9:00 AM - 9:06 AM JST(12:00 AM - 12:06 AM UTC)

[O01-01]Age-Stratified Efficacy of Upadacitinib in Refractory IBD: An Asian Cohort Study on Pediatric Crohn’ s and Geriatric Ulcerative Colitis

Hongzhen Wu Wu1, Tao Su1, Luying Wu1, Min Zhi1, *Jiayin Yao1 (1. Sun Yat-sen University Sixth Affiliated Hospital)
Comment()
9:06 AM - 9:12 AM JST(12:06 AM - 12:12 AM UTC)

[O01-02]Effectiveness and Safety Analysis of Upadacitinib in the
Treatment of Inflammatory Bowel Disease: A Multicenter
Real-World Study

Hongzhen Wu Wu1, Tao Su1, Luying Wu1, Min Zhi1, *Jiayin Yao1 (1. Sun Yat-sen University Sixth Affiliated Hospital)
Comment()
9:12 AM - 9:18 AM JST(12:12 AM - 12:18 AM UTC)

[O01-03]Therapeutic Preferences of Upadacitinib for Patients with Inflammatory Bowel Diseases: A Nationwide Study Among Chinese Physicians

*Lingya Yao1,2, Yining Xu1,2, Wenhao Xia1,2, Kaituo Huang1,2, Qian Cao1,2 (1. Department of Gastroenterology, Sir Run Run Shaw Hospital, College of Medicine Zhejiang University, Hangzhou 310016, China, 2. Inflammatory bowel disease center, Sir Run Run Shaw Hospital, College of Medicine Zhejiang University, Hangzhou 310016, China)
Comment()
9:18 AM - 9:24 AM JST(12:18 AM - 12:24 AM UTC)

[O01-04]Real World Outcomes of Upadacitinib Therapy for Patient with Inflammatory Bowel Disease in Korea: A Multicenter study

*Min Kyu Kim1, Hyuk Yoon2, Eun Soo Kim3, Seung Bum Lee4, Seong-Joon Koh5, Sang-Bum Kang6, Sung Wook Hwang1, Sang Hyoung Park1, Suk-Kyun Yang1, Byong Duk Ye1 (1. Asan Medical Center, 2. Seoul National University Bundang Hospital, 3. Kyungpook National University, 4. Ulsan University Hospital, 5. Seoul National University Hospital, 6. Daejeon St. Mary’s Hospital)
Comment()
9:24 AM - 9:30 AM JST(12:24 AM - 12:30 AM UTC)

[O01-05]Efficacy and Safety of Upadacitinib in Chinese Patients with Inflammatory Bowel Disease: A Multicenter, Prospective, Real-World Study (EaseUpIBD Study)

*Lang Lin1, Jian Tang1, Kang Chao1, Xiang Gao1 (1. The Sixth Affiliated Hospital of Sun Yat-sen University)
Comment()
9:30 AM - 9:36 AM JST(12:30 AM - 12:36 AM UTC)

[O01-06]Endo-histologic outcomes in patients with ulcerative colitis responding to tofacitinib

*Arshdeep Singh1, Arshia Bhardwaj1, Riya Sharma1, Aminder Singh1, Vikram Narang1, Harpreet Kaur1, Ramit Mahajan1, Vandana Midha1, Ajit Sood1 (1. Dayanand Medical College and Hospital, Ludhiana, India)
Comment()
9:36 AM - 9:42 AM JST(12:36 AM - 12:42 AM UTC)

[O01-07]Long-term Efficacy, Safety, and Dose Reduction of Tofacitinib for Refractory Ulcerative Colitis

*Yoriaki Komeda1, Masashi Kono1, Tomoyuki Nagai1, Naoko Tsuji1, Masatoshi Kudo1 (1. Kindai University, Faculty of Medicine, Department of Gastroenterology and Hepatology)
Comment()
9:42 AM - 9:48 AM JST(12:42 AM - 12:48 AM UTC)

[O01-08]Long-term impacts of filgotinib on bowel and systemic symptoms in patients with ulcerative colitis: a post hoc analysis of the SELECTION and SELECTION long-term extension trials

*Fumihito Hirai1, Stefan Schreiber2, Armando Lunello3, Chisa Nagakura4, Toshihiko Kaise4, Toshifumi Hibi5 (1. Department of Gastroenterology and Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, 2. Department Medicine I, University Hospital Schleswig-Holstein, Kiel, Germany, 3. Alfasigma S.p.A., Milan, Italy, 4. Gilead Sciences K.K., Tokyo, Japan, 5. Center for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan)
Comment()
9:48 AM - 9:54 AM JST(12:48 AM - 12:54 AM UTC)

[O01-09]Effectiveness and Safety of Filgotinib in Japanese Patients with Ulcerative Colitis: A Single-Center Retrospective Study

*Ke Han1, Yusuke Yoshimatsu1, Shinya Sugimoto1, Hiroki Kiyohara1, Yohei Mikami1, Tomohisa Sujino2, Kaoru Takabayashi2, Takanori Kanai 1 (1. Division of Gastroenterology and Hepatology, Department of Internal of Medicine, Keio University School of Medicine, 2. Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine)
Comment()
9:54 AM - 10:00 AM JST(12:54 AM - 1:00 AM UTC)

[O01-10]Clinical trajectory of refractory ulcerative colitis from the view point of filgotinib tapering

*KEI MORIYA1, Shinsaku Nagamatsu1, Yuya Nishio1, Yuya Matsuo1, Kyohei Matsuura1, Shoma Kikukawa1, Yuki Fujimoto1, Keisuke Nakanishi1, Hideki Matsuo1, Masakazu Uejima1 (1. Nara Prefecture General Medical Center)
Comment()
10:00 AM - 10:06 AM JST(1:00 AM - 1:06 AM UTC)

[O01-11]Combination therapy With Biologics or Small Molecules for Inflammatory Bowel Disease: A Case Series and Meta-analysis

*Xiaojun Zhuang1, Zihan Chen1, Minhu Chen1, Zhirong Zeng1 (1. The First Affiliated Hospital of Sun Yat-sen University)
Comment()
10:06 AM - 10:12 AM JST(1:06 AM - 1:12 AM UTC)

[O01-12]Ustekinumab and low-dose Upadacitinib combination therapy in medically difficult-to-treat patients with Crohn’s disease: a real-world single-center respective cohort study

*Xiaolei Wang1, Xiaoli Zhu1 (1. Department of Gastroenterology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, China)
Comment()
10:12 AM - 10:15 AM JST(1:12 AM - 1:15 AM UTC)

[23001-12-13add]Oral Presentaion

Comment()
Back to Category List